Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rocket Pharmaceuticals (RCKT) Goodwill: 2018-2024

Historic Goodwill for Rocket Pharmaceuticals (RCKT) over the last 7 years, with Dec 2024 value amounting to $39.2 million.

  • Rocket Pharmaceuticals' Goodwill changed negligibly% to $39.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $39.2 million, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $39.2 million for FY2024, which is negligibly% changed negligibly from last year.
  • According to the latest figures from FY2024, Rocket Pharmaceuticals' Goodwill is $39.2 million, which was down 0.00% from $39.2 million recorded in FY2023.
  • Over the past 5 years, Rocket Pharmaceuticals' Goodwill peaked at $39.2 million during FY2022, and registered a low of $30.8 million during FY2020.
  • Over the past 3 years, Rocket Pharmaceuticals' median Goodwill value was $39.2 million (recorded in 2024), while the average stood at $39.2 million.
  • Data for Rocket Pharmaceuticals' Goodwill shows a peak YoY climbed of 27.21% (in 2022) over the last 5 years.
  • Yearly analysis of 5 years shows Rocket Pharmaceuticals' Goodwill stood at $30.8 million in 2020, then remained steady at $30.8 million in 2021, then grew by 27.21% to $39.2 million in 2022, then remained steady at $39.2 million in 2023, then remained steady at $39.2 million in 2024.